AST5902 trimesylate is the principal metabolite of Alflutinib (AST2818) both in vitro and in vivo. AST5902 trimesylate exerts antineoplastic activity. Alflutinib is an EGFR inhibitor[1].
Molecular Weight:
842.88
Purity:
98.75
CAS Number:
[2929417-90-1]
Formula:
C30H41F3N8O11S3
Target:
Drug Metabolite,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted